Home » Isotechnika Partner Files for Approval of Voclosporin in US, Europe
Isotechnika Partner Files for Approval of Voclosporin in US, Europe
Isotechnika Pharma Inc. Thursday announced that its partner, Lux
Biosciences, Inc., has filed a New Drug Application with the U.S. Food and Drug Administration and a Market Authorization Application with the European
Medicines Agency for voclosporin, under the proposed brand name, LUVENIQ.
CNW Group
CNW Group
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May